| Panekès Partners SGR S.p.A.. (2/16/23). "Press Release: Panakès Partners Announces the Final Closing of the »Purple« Fund at 175 Million Euros". Milan. |
2023-02-16 |
| Epigenomics AG. (2/15/23). "Press Release: Epigenomics Decides to Restructure to Minimize Costs". Berlin & San Diego, CA. |
2023-02-15 |
| Qiagen N.V.. (2/14/23). "Press Release: Qiagen’s Tuberculosis Blood Test QuantiFERON-TB Gold Plus Gains CE-marking Under New EU IVDR Framework". Venlo. |
2023-02-14 |
| Life Science Valley Ventures Management GmbH. (2/13/23). "Press Release: New Fund for Promoting Life Science Start-ups in Lower Saxony". Göttingen. |
2023-02-13 |
| Hexagon Bio, Inc.. (2/13/23). "Press Release: Hexagon Bio Raises $77.3 Million Series B Financing and Strengthens Leadership to Expand Novel Computational Discovery Platform and Advance Microbial Genome-Derived Small Molecules". Menlo Park, CA. |
2023-02-13 |
| Bayer AG. (2/13/23). "Press Release: Bayer Completes Acquisition of Blackford Analysis Ltd. [not intended for U.S. and UK Media]". Berlin. |
2023-02-13 |
| Cydar Ltd.. (2/13/23). "Press Release: Cydar Medical Raises $11.5M (£9.3M) in Series A Funding Round". Cambridge. |
2023-02-13 |
| Hookipa Pharma Inc.. (2/13/23). "Press Release: Hookipa Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers". New York, NY & Vienna. |
2023-02-13 |
| Eppendorf SE. (2/13/23). "Press Release: New Production Site in Shanghai Metropolitan Region". Shanghai & Hamburg. |
2023-02-13 |
| Freeline Therapeutics Holdings plc. (2/10/23). "Press Release: Freeline Announces Closing of Sale of Its CMC-focused German Subsidiary". London. |
2023-02-10 |
| BioNTech SE. (2/10/23). "Press Release: Pfizer and BioNTech Initiate Phase 1/2 Study of First mRNA-based Shingles Vaccine Program". New York, NY & Mainz. |
2023-02-10 |
| Evotec SE. (2/10/23). "Press Release: Evotec Receives € 150 m Loan from European Investment Bank". Hamburg & Toulouse. |
2023-02-10 |
| Icosagen AS. (2/8/23). "Press Release: InvestEU – EIB Agrees to a €18 Million Loan to Estonian Biotech Icosagen for Innovative R&D Technologies and New cGMP Production Facility". Tartu. |
2023-02-08 |
| TVM Capital Life Science. (2/8/23). "Press Release: TVM Capital Life Science Announces Creation of LAmAb Biologics to Develop Innovative Preventative Therapy for Allergy Patients". Montréal, QC & Munich. |
2023-02-08 |
| BRAIN Biotech AG. (2/8/23). "Press Release: Structural Proteins for the Development of Sustainable Materials. BRAIN Biotech and AMSilk Cooperate to Develop High-performance Bio-based Protein Fibers". Zwingenberg & Neuried. |
2023-02-08 |
| Spexis AG. (2/8/23). "Press Release: Spexis and SPRIM Global Investments (SGI) Announce Plans for Clinical Trial Partnership to Fund up to Half of the Projected Phase 3 Clinical Development Costs of ColiFin (Ad hoc annuncement)". Allschwil. |
2023-02-08 |
| CureVac N.V.. (2/8/23). "Press Release: CureVac Announces Pricing of Upsized Public Offering of Common Shares". Tübingen & Boston, MA. |
2023-02-08 |
| APK AG. (2/8/23). "Press Release: LyondellBasell and KIRKBI Invest in APK to Develop Recycling technology". Rotterdam, Billund & Merseburg. |
2023-02-08 |
| BrainRepair UG. (2/8/23). "Press Release: Breakthrough – EUR 50 Million Investment for Start-up BrainRepair UG". Bochum. |
2023-02-08 |
| Bayer AG. (2/8/23). "Press Release: Bill Anderson to Become CEO of Bayer AG". Leverkusen. |
2023-02-08 |
| Molecular Devices, LLC. (2/7/23). "Press Release: Molecular Devices Partners with Seed Biosciences to Exclusively Offer DispenCell Single-Cell Dispenser, Expanding Leadership in Cell Line Development". San José, CA. |
2023-02-07 |
| Formycon AG. (2/7/23). "Press Release: Enno Spillner Appointed Chief Financial Officer (CFO) of Formycon AG". Munich. |
2023-02-07 |
| Qiagen N.V.. (2/7/23). "Press Release: Qiagen Exceeds Outlook for Fourth Quarter and Full-year 2022 with 14% CER Sales Growth in FY 2022 from Non-COVID Product Groups". Venlo. |
2023-02-07 |
| Evotec SE. (2/7/23). "Press Release: Laetitia Rouxel to Succeed Enno Spillner as Chief Financial Officer". Hamburg. |
2023-02-07 |
| Oxford Science Enterprises plc. (2/7/23). "Press Release: Oxford Science Enterprises Strengthens Life Sciences Investment Team with Appointment of Sanne de Jongh as Partner". Oxford. |
2023-02-07 |
| CureVac N.V.. (2/6/23). "Press Release: CureVac Announces Proposed Public Offering of Common Shares". Tübingen & Boston, MA. |
2023-02-06 |
| Cellvie Inc.. (2/6/23). "Press Release: Cellvie Closes $5.5M of Additional Funding to Accelerate the Development of Therapeutic Mitochondria Transplantation". Tübingen & Boston, MA. |
2023-02-06 |
| BioNTech SE. (2/2/23). "Press Release: BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility". Mainz. |
2023-02-02 |
| APIS Assay Technologies Ltd.. (2/2/23). "Press Release: Clickmer Systems Receives €1.1m Grant to Deliver Innovative Diagnostic Platform for Fast Pandemic Responsiveness". |
2023-02-02 |
| Patient Square Capital L.P.. (2/1/23). "Press Release: Patient Square Capital Announces Record $3.9 Billion Inaugural Fund". Menlo Park, CA. |
2023-02-01 |
| Medigene AG. (2/1/23). "Press Release: Medigene AG Appoints Pamela Keck as Vice President of Investor Relations and Corporate Communications". Planegg. |
2023-02-01 |
| Ariceum Therapeutics GmbH. (2/1/23). "Press Release: Ariceum Therapeutics Appoints Radioligand Expert, Germo Gericke, M.D., as Chief Medical Officer". Berlin. |
2023-02-01 |
| va-Q-tec AG. (1/30/23). "Press Release: Management and Supervisory Boards of va-Q-tec AG Recommend Acceptance of EQT Private Equity’s Voluntary Public Takeover Offer". Würzburg. |
2023-01-30 |
| Endress+Hauser AG. (1/27/23). "Press Release: Change at the Top of Analytik Jena. Ulrich Krauss Charts New Course; Oliver Klaeffling Set to Become Managing Director". |
2023-01-27 |
| Epigenomics AG. (1/27/23). "Press Release: Resignation of Supervisory Board Chairman Heino von Prondzynski". Berlin. |
2023-01-27 |
| High-Tech Gründerfonds Management GmbH. (1/26/23). "Press Release: Refined Laser Systems Raises €2.7m to Diagnose Cancer in Minutes". Münster. |
2023-01-26 |
| Evotec SE. (1/26/23). "Press Release: Evotec Announces Agreement with Janssen to Develop Immune-based Therapies". Hamburg. |
2023-01-26 |
| Indivumed GmbH. (1/25/23). "Press Release: Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank". San Diego, CA & Hamburg. |
2023-01-25 |
| Co.don GmbH. (1/25/23). "Press Release: Co.don Finally Saved – Investor Has Taken Over the Business Operations of the Leipzig-based Biopharmacy Vompany with an Additional Location in Teltow, Brandenburg". Leipzig & Teltow. |
2023-01-25 |
| Rewind Therapeutics. (1/25/23). "Press Release: Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor". Leuven. |
2023-01-25 |
| Boehringer Ingelheim. (1/24/23). "Press Release: US FDA Accepts Supplemental New Drug Application for Jardiance for Adults with Chronic Kidney Disease". Ingelheim & Indianapolis, IN. |
2023-01-24 |
| Memo Therapeutics AG. (1/24/23). "Press Release: Memo Therapeutics AG Announces Positive Phase I Data with AntiBKV for Treatment of BKV Infection in Renal Transplant Patients". Schlieren. |
2023-01-24 |
| Novartis AG. (1/24/23). "Press Release: Sandoz Announces Agreement to Acquire Leading Antifungal Agent Mycamine from Astellas, Reinforcing Hospital Offering and Leading Anti-infectives Portfolio". Basel. |
2023-01-24 |
| TME Pharma N.V.. (1/23/23). "Press Release: TME Pharma Provides Clinical Update on the GLORIA Expansion Arm Testing NOX-A12 in Combination with Radiotherapy and Bevacizumab in Patients with Glioblastoma". Berlin. |
2023-01-23 |
| Qiagen N.V.. (1/23/23). "Press Release: Qiagen Digital Insights Launches Ultra-fast NGS Analysis Able to Process a Whole Genome in 25 Minutes for a $1 in Cloud Computing Costs". Redwood City, CA & Hilden. |
2023-01-23 |
| Biosynth AG. (1/19/23). "Press Release: Biosynth Hit 1M Products in Catalog. The Widest Catalog to Be the Leading Global Supplier". |
2023-01-19 |
| InSphero AG. (1/19/23). "Press Release: Brenus Pharma and InSphero Receive €1.5 Million in Grants from the European EUROSTARS Fund". Lyon & Schlieren. |
2023-01-19 |
| Bayer AG. (1/19/23). "Press Release: Bayer Launches New Collaboration with Oerth Bio to Further Advance Innovations in Crop Protection". Monheim & Durham NC. |
2023-01-19 |
| ASG Superconductors S.p.A.. (1/18/23). "Press Release: ASG Superconductors and Siemens Healthineers Join Forces to Deliver 10.5T Ultra High Field MRI Systems for Ground-breaking Brain Research". Genoa. |
2023-01-18 |
| Plasmion GmbH. (1/18/23). "Press Release: Plasmion and Agilent Technologies Announce Co-marketing Agreement to Provide Solutions for Life Sciences and Applied Chemical Markets". Augsburg. |
2023-01-18 |
| Medigene AG. (1/18/23). "Press Release: Medigene Receives $3 Million Milestone Payment from 2seventy bio". Planegg. |
2023-01-18 |
| Bayer AG. (1/18/23). "Press Release: Bayer Acquires Blackford Analysis Ltd. Bolstering the company’s Position in Digital Medical Imaging [not intended for U.S. and UK Media]". Berlin. |
2023-01-18 |
| Ruhr-Universität-Bochum. (1/17/23). "Pressemitteilung: Alzheimer-Frühdiagnostik – Spin-Off BetaSense zieht ins BioMedizinZentrum". |
2023-01-17 |
| Pureos Partners AG. (1/17/23). "Press Release: Pureos Partners Welcomes Dr. Ulf Grawunder to Its Team as Venture Partner". Pfäffikon. |
2023-01-17 |
| Ensilicated Technologies Ltd. (EnsiliTech). (1/17/23). "Press Release: Ensilicated Technologies Raises £1.2m to Develop Technology that Eliminates Need for Vaccine Refrigeration". Bristol. |
2023-01-17 |
| ImmunOs Therapeutics AG. (1/17/23). "Press Release: ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002". Schlieren. |
2023-01-17 |
| Qiagen N.V.. (1/17/23). "Press Release: Qiagen Launches EZ2 Connect MDx Platform for Automated Sample Processing in". Venlo. |
2023-01-17 |
| BioGeneration Ventures B.V.. (1/17/23). "Press Release: BGV Appoints Jaap de Bruin as FIRST Fund Investment Manager and Promotes Rianne Ellenbroek to Principal". Amsterdam. |
2023-01-17 |
| Optibrium Ltd.. (1/17/23). "Press Release: Optibrium Appoints Steve Yemm as Chief Commercial Officer". Cambridge. |
2023-01-17 |
| TetraScience, Inc.. (1/12/23). "Press Release: Labforward Joins the Tetra Partner Network to Eliminate Data Silos and Error-Prone Data Transfers". Boston, MA. |
2023-01-12 |
| Bayer AG. (1/11/23). "Press Release: Bayer to Accelerate Drug Discovery with Google Cloud’s High-Performance Compute Power". Berlin & Sunnyvale, CA. |
2023-01-11 |
| CureVac N.V.. (1/10/23). "Press Release: CureVac Appoints Alexander Zehnder as CEO from April 1, 2023". Mainz & London. |
2023-01-10 |
| ProBioGen AG. (1/10/23). "Press Release: ProBioGen Collaborates with Boehringer Ingelheim on DirectedLuck Transposase Technology". Berlin. |
2023-01-10 |
| Sernova Corporation. (1/10/23). "Press Release: Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes". London, ON. |
2023-01-10 |
| Bayer AG. (1/10/23). "Press Release: NextPoint Therapeutics Announces $80 Million Series B Financing Co-led by Leaps by Bayer and Sanofi Ventures to Advance Novel Immuno-Oncology Programs". Cambridge, MA & Leverkusen. |
2023-01-10 |
| Medios AG. (1/10/23). "Press Release: Medios AG. Successful Completion of the Acquisition of bbw – Significant Expansion of Compounding Volume". Berlin. |
2023-01-10 |
| BioNTech SE. (1/10/23). "Press Release: BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development". Mainz & London. |
2023-01-10 |
| Boehringer Ingelheim. (1/9/23). "Press Release: Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies". Ingelheim & South San Francisco, CA. |
2023-01-09 |
| Proteros Biostructures GmbH. (1/9/23). "Press Release: Proteros Receives Minority Investment from Private Equity Firm Inflexion". Martinsried. |
2023-01-09 |
| Idorsia Ltd.. (1/9/23). "Press Release: Idorsia Presents at the 41st J.P. Morgan Healthcare Conference – Achievements in 2022 Provide the Foundation for Our Success in 2023". Allschwil. |
2023-01-09 |
| Qiagen N.V.. (1/9/23). "Press Release: Qiagen Completes Acquisition of Verogen, Strengthening Leadership in Human ID / Forensics with NGS Technologies". Venlo & San Diego, CA. |
2023-01-09 |
| Alentis Therapeutics AG. (1/9/23). "Press Release: Positive Results from Single Ascending Dose Phase 1 Study of ALE.F02 Targeting Claudin-1". Basel. |
2023-01-09 |
| BioNTech SE. (1/6/23). "Press Release: BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030". Mainz. |
2023-01-06 |
| CureVac N.V.. (1/6/23). "Press Release: CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs". Tübingen & Boston, MA. |
2023-01-06 |
| BioVersys AG. (1/5/23). "Press Release: BioVersys Extends Its Series C Round to CHF 32.6 Million with investment from the AMR Action Fund". Basel. |
2023-01-05 |
| Bruker Corporation. (1/5/23). "Press Release: Bruker Announces Acquisition of Acquifer Imaging GmbH". Heidelberg. |
2023-01-05 |
| Bruker Corporation. (1/4/23). "Press Release: Biognosys and Bruker Form Partnership for Advanced Proteomics CRO Services for Global Biopharma and Biomarker Customers". Lausanne. |
2023-01-04 |
| ADC Therapeutics S.A.. (1/4/23). "Press Release: ADC Therapeutics to Participate in the 41st Annual J.P. Morgan Healthcare Conference". Lausanne. |
2023-01-04 |
| Hookipa Pharma Inc.. (1/4/23). "Press Release: Hookipa Pharma Achieves $5 Million Milestone Payment from Gilead Sciences for Progress in the Development of Hepatitis B Vaccine". New York, NY & Vienna. |
2023-01-04 |
| Ethris GmbH. (12/29/22). "Press Release: Cipla EU to Invest EUR 15 million in Ethris, Initiating a Strategic Collaboration". Mumbai & Munich. |
2022-12-29 |
| BioNTech SE. (12/28/22). "Press Release: BioNTech to Present at the 41st Annual J.P. Morgan Healthcare Conference". Mainz. |
2022-12-28 |
| BioNTech SE. (12/23/22). "Press Release: BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165". Mainz. |
2022-12-23 |
| aws Gründerfonds. (12/23/22). "Pressemitteilung: aws Gründerfonds investiert in nachhaltiges Lebensmittel-Startup Arkeon". Tulln & Wien. |
2022-12-23 |
| Merck KGaA. (12/22/22). "Press Release: Merck Announces Collaboration with Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates". Darmstadt. |
2022-12-22 |
| Ryvu Therapeutics S.A.. (12/22/22). "Press Release: Ryvu Therapeutics Announces Closing of Equity Offering with Gross Proceeds over PLN 250 Million". Krakow. |
2022-12-22 |
| Bruker Corporation. (12/21/22). "Press Release: Bruker Corporation to Present at the 41st Annual J.P. Morgan Healthcare Conference". Billerica, MA. |
2022-12-21 |
| ADC Therapeutics S.A.. (12/21/22). "Press Release: ADC Therapeutics and Sobi Announce European Commission Approval of Zynlonta (loncastuximab tesirine) for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma". Lausanne. |
2022-12-21 |
| BioNTech SE. (12/21/22). "Press Release: Update on First BioNTainer for African-based mRNA Manufacturing Facility". Mainz. |
2022-12-21 |
| MDG Molecular Diagnostics Group GmbH. (12/21/22). "Press Release: Molecular Diagnostics Group and Swiss 4D Lifetec AG Become Strategic Partners". |
2022-12-21 |
| BioNTech SE. (12/21/22). "Press Release: BioNTech Starts Phase 1 Clinical Trial for Prophylactic Herpes Simplex Virus-2 Vaccine Candidate BNT163". Mainz. |
2022-12-21 |
| InflaRx N.V.. (12/21/22). "Press Release: InflaRx Announces Amendment of Co-Development Agreement and Additional Equity Investment by Staidson in Connection with Regulatory Filing in China for Anti-C5a-Antibody for Treatment of COVID-19". Jena. |
2022-12-21 |
| Ethris GmbH. (12/21/22). "Press Release: Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses". Munich. |
2022-12-21 |
| MorphoSys AG. (12/20/22). "Press Release: Chief Financial Officer Sung Lee to Leave MorphoSys in March 2023". Planegg. |
2022-12-20 |
| European Invesmtent Bank (EIB). (12/20/22). "Press Release: Germany – EIB Provides €20 Million in Financing to Innovative Diagnostics Developer Numares". |
2022-12-20 |
| Boehringer Ingelheim. (12/20/22). "Press Release: Boehringer Ingelheim Announces Appointments to Board of Managing Directors". Ingelheim. |
2022-12-20 |
| Eckert & Ziegler Strahlen- und Medizintechnik AG. (12/19/22). "Press Release: Changes in the Management Board of Eckert & Ziegler. Insider Information Pursuant to Article 17 MAR". Cambridge. |
2022-12-19 |
| Boehringer Ingelheim. (12/19/22). "Press Release: Boehringer Ingelheim and Click Therapeutics Expand Their Existing Collaboration to Develop Prescription Digital Therapeutics for Schizophrenia". Ingelheim & New York, NY. |
2022-12-19 |
| CRISPR Therapeutics AG. (12/19/22). "Press Release: CRISPR Therapeutics Announces the Appointment of Alex Harding, M.D., M.B.A., as Head of Business Development". Zug & Boston, MA. |
2022-12-19 |
| CN Bio Innovations Ltd.. (12/19/22). "Press Release: CN Bio Appoints Dr Paul Brooks as Chief Executive Officer". Cambridge. |
2022-12-19 |
| ADC Therapeutics S.A.. (12/19/22). "Press Release: ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer". Lausanne. |
2022-12-19 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 6 7 8 ... 55 56 57 
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
